Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Inappropriate Reconstitution Technique; diluent only portion of Hiberix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate dose of vaccine administered in a infant female patient who received Hib (Hiberix) for prophylaxis. On an unknown date, the patient received the 1st dose of Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Inappropriate Reconstitution Technique) and inappropriate preparation of medication (Verbatim: diluent only portion of Hiberix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown. Additional Information: GSK Receipt Date: 09-JAN-2025 Pharmacist states she was contacted by a clinic staff member who was concerned that they might have administered the diluent only portion of Hiberix to a patient within the past 1 to 2 months. The staff does not know for sure if this happened and did not know which patient it would have been, but they did had it narrowed down to 5 patients, of which one of them could have received diluent only, which led inappropriate preparation of medication and inappropriate dose of vaccine administered. It was possible that the 5 patients might all be given another dose, but at the time of reporting this decision has not been made. The reporter consented to follow up.; Sender's Comments: US-GSK-US2025002645:Same reporter/Different Patient US-GSK-US2025002639:Same reporter/Different Patient US-GSK-US2025002641:Same reporter/Different patient US-GSK-US2025002649:Same reporter/Different patient